INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results